ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 135 filers reported holding ARGENX SE in Q3 2019. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,788,550 | +142864.6% | 85,000 | +13.3% | 2.22% | +64.1% |
| Q2 2023 | $29,230 | -99.9% | 75,000 | -56.1% | 1.36% | -24.8% |
| Q3 2021 | $51,620,000 | +0.3% | 170,926 | 0.0% | 1.80% | -0.7% |
| Q2 2021 | $51,461,000 | +9.3% | 170,926 | 0.0% | 1.82% | +13.8% |
| Q1 2021 | $47,071,000 | -6.4% | 170,926 | 0.0% | 1.60% | -1.2% |
| Q4 2020 | $50,268,000 | +12.0% | 170,926 | 0.0% | 1.62% | +4.2% |
| Q3 2020 | $44,871,000 | +16.6% | 170,926 | 0.0% | 1.55% | -8.4% |
| Q2 2020 | $38,498,000 | +46.1% | 170,926 | -14.5% | 1.69% | -5.7% |
| Q1 2020 | $26,346,000 | -17.9% | 200,000 | 0.0% | 1.80% | -1.1% |
| Q4 2019 | $32,104,000 | +40.9% | 200,000 | 0.0% | 1.82% | +9.9% |
| Q3 2019 | $22,792,000 | -19.5% | 200,000 | 0.0% | 1.65% | -32.1% |
| Q2 2019 | $28,316,000 | – | 200,000 | – | 2.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |